Reinventing the Indian pharma business is no longer a choice but an imperative: EY report

Reinventing the Indian pharma business is no longer a choice but an imperative: EY report: As Indian pharma companies prepare to shift from supplying commodities to supplying innovations, technology is altering the way health care is imagined and delivered, according to an EY report

VARINDIA- INDIA'S FRONTLINE IT MAGAZINE

Comments

Popular posts from this blog

N Chandrasekaran appointed chairman of Tata Sons

Visa buys NFT based CryptoPunk and paid $150,000 in Etherium

Prizm Payment Services changes its name to Hitachi Payment Services